Mutation analysis ofASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12,andTET2in myeloproliferative neoplasms-Reference-Cited by-同舟云学术

Mutation analysis ofASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12,andTET2in myeloproliferative neoplasms

Published:2012-04-09 Issue:8 Volume:51 Page:743-755
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Brecqueville Mandy,Rey Jérôme,Bertucci François,Coppin Emilie,Finetti Pascal,Carbuccia Nadine,Cervera Nathalie,Gelsi-Boyer Véronique,Arnoulet Christine,Gisserot Olivier,Verrot Denis,Slama Borhane,Vey Norbert,Mozziconacci Marie-Joelle,Birnbaum Daniel,Murati Anne

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference51 articles.

1. Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias;Abdel-Wahab;Cancer Res,2010

2. DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms;Abdel-Wahab;Leukemia,2011a

3. Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms;Abdel-Wahab;Leukemia,2011b

4. Myelodysplastic syndromes: Lost between two states?;Acquaviva;Leukemia,2010

5. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia;Boultwood;Leukemia,2010

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Presence of triple positive driver mutations in JAK2, CALR and MPL in primary myelofibrosis: a case report and literature review;Hematology;2024-09-13

2. Targeting lysine demethylase 6B ameliorates ASXL1 truncation–mediated myeloid malignancies in preclinical models;Journal of Clinical Investigation;2024-01-02

3. A Case of Chronic Eosinophilic Leukemia with CSF3R-Mutant Clone and Transformed to Secondary Acute Myeloid Leukemia;Clinical Laboratory;2024

4. SRSF2 mutation cooperates with ASXL1 truncated alteration to accelerate leukemogenesis;Leukemia;2023-11-28

5. Molecular diagnostic criteria of myeloproliferative neoplasms;Expert Review of Molecular Diagnostics;2023-11-24